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ABSTRACT
The recently proposed glymphatic system suggests that bulk flow is important for clearing waste from the brain, and as
such may underlie the development of e.g. Alzheimer’s disease. The glymphatic hypothesis is still controversial and several
biomechanical modeling studies at the micro-level have at least partially dismissed the system and its assumptions. In contrast,
at the macro-level, there are many experimental findings in support of bulk flow. Here, we will investigate to what extent the
CSF tracer distributions seen in novel magnetic resonance imaging (MRI) investigations over hours and days are suggestive of
bulk flow or diffusion. In order to include the complex geometry of the brain, the heterogeneous CSF flow around the brain, and
the transport over the time-scale of days, we employed the methods of partial differential constrained optimization to identify
the apparent diffusion coefficient (ADC) that would correspond best to the MRI findings. We found that the computed ADC in
grey and white matter was respectively 23% and 82% larger than the ADC estimated with DTI, which suggests that diffusion
may not be the only mechanism governing transport.
Introduction
Most types of dementia are associated with accumulation of metabolic by-products within the brain. In contrast to the rest of the
body, the brain lacks a lymphatic system to clear these by-products. In 2012, a new pathway, called the paravascular pathway,
was proposed1, which enables efficient brain-wide circulation and clearance. The network of paravascular pathways in the brain
was named the glymphatic system as it resembles the lymphatic system in the rest of the body, while the ’g’ in glymphatic
highlights the importance of the supportive glia cells in the brain. The paravascular pathways consists of cerebrospinal fluid
flowing in parallel with the vasculature in paravascular spaces. These pathways have the potential to facilitate exchange between
the cerebrospinal fluid (CSF) and the extracellular fluid deep within the brain.
To what extent and at what scale the glymphatic system accelerates transport compared to extracellular diffusion is still
controversial, and several computational modeling studies have dismissed parts of the system at micro-scale. For example,
the previous studies2, 3 suggest that diffusion dominates in the interstitium. Furthermore, 4–6 have found that dispersion in the
paravascular spaces adds less than a factor two to diffusion for solute transportation. However, multiple experimental and
imaging findings at the micro-level point towards transport being different and faster than diffusion1, 7, 8.
Investigation of the paravascular transport at macro-scale was proposed and tested in a rat’s brain9. The procedure involved
injecting MRI contrast agent into the CSF and subsequently imaging the transportation of the MRI contrast agent at multiple
time-points during a few hours after the injection. The MRI contrast agent worked as a CSF tracer, and was brain-wide in
the rat after a few hours. The procedure was tested in humans for the first time in 201710 with acquisition of MRI images
repeatedly during 48 hours after the injection and later quantified in a region-specific manner in 201811 in individuals with
dementia and controls. Overall, the MRI contrast agent transportation showed a centripetal pattern in all participants, but the
MRI contrast agent was more protracted in individuals with dementia compared with controls11. It was also noted that the
CSF-tracer transport appeared faster than what can be expected from diffusion in simplified planar geometries.
On this background, our purpose in this paper is to explore whether the CSF tracer distribution seen in11 can be explained
by diffusion alone, as predicted by the seminal work of Syková and Nicholson12. We will investigate this hypothesis with finite
element simulations of the diffusion process combined with a parameter identification procedure for the apparent diffusion
coefficients (ADCs). Thus, we aim to investigate whether we can assess ADC on long time-scales (hours or days), by fitting
a diffusion model to the MRI data obtained at multiple time-points when the CSF tracer is propagating through the brain.
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This includes taking into account the complexity of the folding brain surface by constructing a patient-specific geometry. We
propose that if the fit between images and our model is good and we identify ADC values that are in line with those predicted
by diffusion tensor imaging (DTI) then enhanced solute transport of the MRI contrast agent in question can be ignored. Our
approach for the parameter identification is to solve an optimization problem constrained by a diffusion equation with unknown
coefficients, where the optimization targets the observed CSF tracer concentrations at the 10 available acquisitions during 24
hours after CSF tracer injection.
An outline of the paper is as follows: In Section 1, we present the methodology of the paper. We start in Section 1.3
with a detailed description of the medical imaging methods relevant for this study. Section 1.4 describes the mathematical
models, and the computational methodology for this paper. In Section 2, we will present the results of the study, starting
with the MRI analysis in Section 2.1. We continue in Section 2.2 with a synthetic test case, which involves finding robust
regularization parameters with a uniform distributed noise added to the images. The construction of the synthetic test case and
the concentration estimation can be found in the Supplementary. While in Section 2.3, we present the computed ADC using
the MRI images, and compare the values with ADC estimated with DTI. In Section 2.3.2, we present the results of different
method to decrease the boundary noise. The results will facilitate the general discussion in Section 3.
1 Methods
1.1 Simulation workflow
An overview of the simulation workflow for this paper is outlined in Fig. 1. We obtained MRI data for one patient, which
included MRI images with MRI contrast agent at different times (Box A in Fig. 1). The first MRI image was segmented and used
to construct a patient specific mesh (Box B in Fig. 1). MRI images were used for estimating the CSF tracer concentration for the
different times, and were subsequently sampled onto the patient specific mesh (Box C in Fig. 1). The sampled concentrations at
the different times were then used with the mathematical model (Box D in Fig. 1). Values for numerical and regularization
parameters were inputs for the computation (Box E in Fig. 1). The simulations produced the optimal ADC for grey and white
matter to explain the observations for different input parameters(Box F in Fig. 1).
1.2 Approvals and MRI Acquisition
The approval for MRI observations was retrieved by the Regional Committee for Medical and Health Research Ethics (REK) of
Health Region South-East, Norway (2015/96) and the Institutional Review Board of Oslo University Hospital (2015/1868) and
the National Medicines Agency (15/04932-7). The study participants were included after written and oral informed consent.
The MRI images included 3D T1-weighted volume, sagittal 3D FLAIR, DTI and T1 map for the same patients. All methods
were performed in accordance with the relevant guidelines and regulations
The contrast observations were obtained using a 3 Tesla Philips Ingenia MRI scanner (Philips Medical Systems) with the
same imaging protocol settings at all time points to acquire sagittal 3D T1-weighted volume scans. The imaging parameters
were as follows: repetition time, “shortest” (typically 5.1 ms); echo time, “shortest” (typically 2.3 ms); flip angle, 8 degrees;
field of view, 256 × 256 cm; and matrix, 256 × 256 pixels (reconstructed 512 × 512). We also obtained observation a sagittal
3D FLAIR volume sequence of the same patient, that was taken before the injection of contrast. The main imaging parameters
were; repetition time = 4,800 ms; echo time 318 ms; inversion recovery time, 1,650 ms; field of view, 250 × 250 mm; and
matrix, 250 × 250 pixels (reconstructed 512 × 512). The T1 map was obtained with a MOLLI5(3)313 sequence with the
following imaging parameters; repetition time 2.3 ms; echo time 1.0 ms; flip angle 20; field of view 257 × 257; and matrix 240
× 240 pixels. The DTI acquisition was done with the parameters; repetition time 12171 ms; echo time 60.0 ms; flip angle 90;
field of view 240 × 240; and matrix 96 × 96 pixels.
1.3 MRI Analysis
A time sequence of T1-weighted MRI images showing the CSF- and brain enhancement in a patient diagnosed with NPH during
48 hours after intrathecal administration of Gadobutrol was obtained from a previous study11. The software FreeSurfer14–17
was used to segment and align each of the observations, which made it possible to estimate voxelwise signal increase. Figure 2
shows the distribution of MRI contrast agent in a selected region, as a percentage change in MRI signal unit ratios. The full
data set used in this study (not all shown) consists of 10 MRI images, including a baseline MRI image taken before the contrast
agent was injected. The MRI scans were obtained at different times distributed over 5 scans within 1-2 hours after injection, a
single MRI scan at 2 hours, 6 hours, 24 hours and 48 hours. We segmented the baseline image with FreeSurfer and aligned the
other images to the baseline. The exponential relation between the MRI signal values and the CSF tracer concentration, and the
estimation of the concentration for each voxel is documented in the Supplementary 4.3. The estimation of the concentration
produced images similar to the MRI images, but the values have the unit millimolar (mM). Therefore, we will denote the
concentration images as observations to distinguish the concentrations from the MRI image intensities.
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Figure 1. Schematic description of the simulation workflow, outlined through panels A to F.
The segmentation process also produced polyhedral surfaces of the white and cortical grey matter that were used for mesh
construction. We used the Computational Geometry Algorithms Library (CGAL)18 to combine the surfaces and construct
the mesh with different subdomains. The computational requirement for the resulting mesh was significant, therefore two
submeshes were also constructed, see Fig. 3. The three domain mesh (white matter, grey matter and CSF compartment),
shown in Fig. 3 A, consists of 244,318 tetrahedral cells and 22,057 vertices, while the two domain mesh (without the CSF
compartment), shown in Fig. 3 B, consists of 183,138 tetrahedral cells and 42,514 vertices.
1.4 Mathematical Model
The macroscopic extracellular diffusion in the brain can be considered a hindered diffusion with an apparent diffusion coefficient
(ADC) depending on the structure of the extracellular space12. The relation between the apparent and free diffusion coefficients
is defined as
λ =
√
D/DADC (1)
with λ denoting the tortuosity of the extracellular space. In order to estimate the ADC involved in the contrast transportation,
shown in Fig. 2, we assume that the process can be modeled by a diffusion equation. Then, we constructed an optimization
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Figure 2. The image shows the percentage change in T1 signal unit ratios from baseline at different observation times in the
slice (marked red in the left panel) used in the subsequent analysis. The color-bar was restricted to the range (0,100). The
upper row shows the axial slice, and the bottom row shows the coronal slice.
Figure 3. The leftmost image A) shows the mesh created from the baseline MRI image with three domains, while the
rightmost image B) shows the mesh created from the baseline MRI image with two domains. The blue domain corresponds to
CSF domain, ΩCSF , the purple domain corresponds to grey matter, ΩGM , and the white domain corresponds to white matter,
ΩWM .
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problem with the aim of minimize the difference between the observed and the modeled contrast distribution by optimizing the
boundary conditions and the apparent diffusion coefficient. Thus enhanced transportation because of effects such as dispersion
would result in an ADC larger than that predicted by DTI. The optimization problem was defined as
min
D,g
n
∑
i=1
∫
Ω
|u(ti)−uobs(ti)|2dΩ+
T∫
0
∫
∂ΩD
(
α
2
|g|2+ β
2
∣∣∣∣∂g∂ t
∣∣∣∣2+ γ2 |∇g|2
)
dΩdt (2)
subject to
∂u
∂ t
= D∇2u in Ω×{0,T )
u= g on ∂ΩD×{0,T )
∂u
∂n
= 0 on ∂ΩN×{0,T )
(3)
Here, u [mM] is the simulated, time-varying CSF tracer distribution, D
[
mm2/s
]
is the ADC, g [mM] is the boundary condition,
Ω is the domain, and T [h] is the final simulation time. We assume that the domain Ω consists of three sub domains, each with
a different ADC. We denote the CSF (subarachnoid and lateral ventricle) domain as ΩCSF , the grey matter as ΩGM and the
white matter as ΩWM . The ADC was assumed to be constant within the CSF, grey and white matter but each region may have
different values. The α , β and γ parameters are non-negative regularization parameters and uobs [mM] are the concentration
distribution at time-points ti [h]. Spacial regularization parameter α enforces smoothness on the boundary by minimizing the
concentration, i.e. high value of α will give less concentration in the optimal solution. Temporal regularization parameter β
enforces smoothness in time on the boundary, i.e. high value of β will give a smoother concentration curve in time. Gradient
regularization parameter γ enforces continuity between adjacent concentrations at the boundary, i.e. high values of γ will give
smoother concentration values at the boundary.
1.4.1 Boundary conditions.
For the three domain geometry (with grey and white matter, and CSF compartment), the Dirichlet boundary condition ΩD was
only applied on the outward facing boundary of the CSF domain, ∂Ω1. Homogeneous Neumann conditions ΩN were applied
on the remaining boundaries.
The implementation of the gradient regularization γ for the case containing only grey and white matter required that the
outward facing boundary was decomposed in different regions to avoid the boundary values being continuous at the interface
between CSF, grey and white matter. We decomposed the boundary as seen in Fig. 4, with the red and blue boundary adjacent
to the CSF. We defined the red boundary ∂Ωr and the blue boundary ∂Ωb as Dirichlet boundaries ΩD, while the green and
yellow were Neumann boundaries ΩN . The regularization parameter γ was subsequently set to be non-zero in (2). We initially
tested gradient regularization with the same parameter γ on both boundaries, but the different distribution of tracers on the
boundaries made it difficult to find an adequate value for γ . This may be attributed to the fact that the concentration in the
lateral ventricles were more uniform than that in the SAS, so we defined γ as
γ =
{
0.01γ˜ ∈ ∂Ωb
γ˜ ∈ ∂Ωr
(4)
with γ˜ as the referenced, i.e. mentioned in the text, regularization parameter.
1.4.2 Synthetic test case with a manufactured solution.
In order to assess the robustness and accuracy of the methodology of ADC estimation via PDE constrained optimization we
constructed a synthetic test case with a known, manufactured solution. The setup for the numerical tests can be found in the
Supplementary 4.1. In the case of three domains we varied α ∈ (10−6,10−2) and β ∈ (10−6,102). In the case of two domains
α ∈ (10−6,1), β ∈ (10−4,102) and γ ∈ (10−4,1.0).
We tested the noise susceptibility with a uniform distributed of noise. This was done by adding noise in the range of
(−namp,namp) to the observation after loading, i.e. each vertex. We tested the noise with namp ∈ (0.03,0.15,0.30,0.475),
compared to the maximum values for the manufactured solution being in the range (0.3,1.3) for all times. We used the
observation with the added noise to compute and confirm the expected SNR, since there was a finite number of vertices. The
variation in the number of observations was tested with 5,10 and 20 evenly spaced observations over the course of 24 hours
combined with 10 times steps, 20 time steps and 40 time steps.
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Figure 4. The images shows the different boundary values on the mesh, with each color representing a unique boundary.
1.5 CSF tracer distribution reconstruction from MRI data
The MRI data consisted of scans at times ti that were distributed in the 48 hours time frame, with the first observation with
tracer occurring 1-2 hours after the injection. This was followed by 4 observations within the first hour, and we observed no
visible change in the tracer distribution for these observations. Therefore, we used observation times listed in Tab. 1 for the
computation of the ADC values.
1.5.1 Comparison with data obtained from DTI analysis
We compared the ADC computed by solving (2)-(3) with ADC values obtained from the DTI image of the same patient. We
remark that a direct comparison with DTI is not possible because DTI measures the ADC of water. Therefore, we used the DTI
to estimate the tortuosity in grey and white matter, which together with the free diffusion coefficient of Gadobutrol and (1) can
be used to approximate ADC for Gadobutrol, details and references are found in the Supplementary 4.4.
1.5.2 Preprocessing of concentrations of Gadobutrol at ventricular and subarachnoid surfaces
High frequency concentration changes was observed at the boundaries of our mesh, see top row of column A in Fig. 6 and Fig. 7,
which can be interpreted as sampling errors. Such errors may be caused by noise in the MRI data, errors in the segmentation, the
segmented polyhedral surfaces which typically cut voxels, miss-alignment between different observations, and by the inaccuracy
of sampling discontinuous voxel data. Therefore, we investigated two approaches to reduce high frequency components at
mesh boundaries:
• A projection of the segmented CSF Gadobutrol concentrations directly at the ventricle and subarachnoid surfaces (CP),
• A Gaussian smoothing (GS) procedure.
In detail, the CP method was implemented by finding the voxel corresponding to each boundary vertex on Ωb and Ωr using
an affine transformation matrix in FreeSurfer. Then, for each voxel, we computed the average of all surrounding voxels with
CSF segmentation mark in a 7×7×7 matrix. The average values were then used at the corresponding boundary vertex in the
computations. In order to estimate the CSF concentration, we assumed that the T1 value corresponding to CSF was 3000 ms.
Finally, for the GS method we used the Gaussian smoothing function found in the python-module scipy19, and applied the
smoothing to all voxel in the observations estimated from MRI images. The standard deviation of the Gaussian distribution was
set to 1.5 mm2 compared to MRI voxel length of 1.0 mm. In addition to the CP and GS methods, we also use the raw data
without any preprocessing. This method is referred to as RAW.
We performed the simulations with the regularization parameters α ∈ (10−6,10−4),β ∈ (1.0,10),γ ∈ (0.0,0.01,1.0).
Additionally, we ran simulation with β = 100 and γ = 100 to obtain simulations that clearly showed differences in the
concentration distributions on the boundary.
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Description Model variable Value used in the simulation
Number of timesteps k 24, 48
Observational time points τ {0.0,2.1,6.1,24.1,47.8}
Timestep dt 1, 2 hours
Spacial Regularization α {10−6,10−4}
Time Regularization β {1.0,10.0}
Gradient Regularization β {0.0,0.01,1.0}
Table 1. The table shows an overview of the parameters used for boundary constrained optimization with MRI data.
2 Results
2.1 MRI Analysis
Statistical analysis was done on the observations to determine the signal to noise ratio (SNR) for each observation. The first 5
observations had SNR in the range 0.6-0.8 in grey matter and 0.2-1.3 in white matter. For the remaining observations the SNR
ranged 1.4-1.9 in grey matter and 1.3-2.6 in white matter.
2.2 Assessment of accuracy and robustness on a synthetic test case
For the first geometry, involving CSF, grey and white matter, we ran a series of 448 tests with different regularization parameters
α and β using the manufactured solutions with observations every 2.4 hours over the course of 24 hours. It was found that for
α ∈ (10−6,10−2) and β ∈ (10−6,1.0), the error in the ADC for CSF, grey and white matter was less than 5%. For combinations
with β = 102, the smallest error was 63.6% in the CSF, 10.8% in grey matter and 3.5% in white matter. While for α = 1.0, the
smallest error was 160.2% in the CSF, 23.2% in grey matter and 8.9% in white matter. Second, the robustness of the parameter
identification process with respect to noise in the data was investigated. The noise values were randomly obtained from a
uniform distribution in the range (-0.3,0.3), where 0.3 equaled the maximum initial value of the manufactured solution and was
23% of the manufactured solution at its max. Again, for α ∈ (10−6,10−2) and β ∈ (10−6,1.0) the error in the ADC in CSF
was less than 23% and less than 9.7% in grey and white matter.
For the second geometry, including only grey and white matter, we ran a selection of 186 tests to ensure that the results
were consistent. The boundary conditions were applied to the boundaries of the SAS and lateral ventricle. In the range
α ∈ (10−6,10−2) and β ∈ (10−4,1.0), the error was less than 4.2% for the ADC in both grey and white matter.
The noise susceptibility was tested with the addition of the regularization parameter γ ∈ (0.0,10−2,1.0), which enforces
smoothness at the boundary. We computed the error on the SAS boundary and on the lateral ventricle boundary, and it was
observed that γ did not contribute to a lower error in the ADC, but decreased the boundary error with a few percentage on
average. In the range α ∈ (10−6,10−4) and β ∈ (10−4,1.0), we had maximum error of 7.0% in the grey matter and 3.1% in the
white matter with noise randomly obtained from the uniform distribution range of (-0.3,0.3). The computed the SNR of 0.74 for
first time step, and increased to the maximum of 6.3.
The synthetic test case revealed that the second geometry, involving only the estimation of ADC in grey and white matter
was the most accurate method. Hence, in the following, only the second geometry was used.
2.3 CSF tracer distribution recondstrction from MRI data
In the synthetic case we managed to reproduce the ADC within 7% error for a wide range of parameters, α ∈ (10−6,10−2),
β ∈ (10−4,1.0), and γ ∈ (0.0,10−2,1.0). The same parameters were then used to compute the optimal ADC for the CSF tracer
estimated from MRI images. A few of the reconstructions are shown in Fig. 5. It is clear that our model assumption of an
underlying diffusion equation is adequate, that is; from a visual point of view the observed data in Fig 5, row A, is reconstructed
accurately for the various different regularization parameters Fig 5, row B-D. We computed the average ADC over the range of
regularization parameters to be 0.57±0.05 mm2/h in grey matter and 0.72±0.02 mm2/h in the white matter, which respectively
corresponds to 1.6±0.2×10−4mm2/s and 2.0±0.1×10−4mm2/s, shown in Fig. 8.
2.3.1 Comparison with data obtained from DTI analysis
The median ADC for water in the DTI was estimated to be 1.0±0.4×10−3mm2/s in grey matter and 0.9±0.3×10−3mm2/s
in white matter resulting in a tortuosity of 1.73 and 1.85 based on (1). The free diffusion coefficient for Gadobutrol was
approximated to be 3.8× 10−4mm2/s in the Supplementary 4.4. This gives an estimate median Gadobutrol ADC to be
1.3±0.5×10−4mm2/s in the grey and 1.1±0.4×10−4mm2/s in the white matter. This estimation assumed that the tortuosity
was independent for molecules with mass lower than 1kDa. For Gadobutrol, this gives an average of 23±15% larger ADC in
grey matter and 82±10% larger ADC in white matter compared to the associated ADC values based on DTI.
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Figure 5. The image displays observations from MRI images and computational reconstruction of the same observations at
observational time-points, i.e. 2 hours, 6 hours, 24 hours and 48 hours after the administration of CSF tracer. Row A) shows the
observations estimated from MRI images. Row B) shows the reconstructed observations with α = 0.0001,β = 10.0,γ = 1.0
and 48 time steps. Row C) shows reconstructed observations with α = 10−6,β = 1.0,γ = 0.01 and 48 time steps. Row D)
shows reconstructed observations with α = 10−6,β = 10.0,γ = 1.0 and 48 time steps. The color-bar was restricted to the
range (0.0-0.8).
8/20
Figure 6. The images shows the SAS boundary after 12 hours. The upper row shows the observations with following
preprocessing left to right: Raw observations, projection of CSF value onto the boundary, Gaussian smoothing. The middle row
shows the corresponding states with the regularization parameters α,β ,γ = (10−6,1.0,1.0). The bottom row shows the
corresponding states with the regularization parameters α,β ,γ = (10−6,100.0,100.).
2.3.2 Preprocessing of concentrations of Gadobutrol at ventricular and subarachnoid surfaces
The three different reconstructions with RAW, CP and GS methods are illustrated in Fig. 6 and Fig. 7 for some different
regularization parameters. As can be seen in RAW column in Fig. 6 and Fig. 7 the boundary gradient regularization γ caused
the concentration to be more uniform on the boundary and in particular for the high value γ = 100. The CP method results in
similar values for most of the ventricular boundary. The resulting ADC Gadobutrol values for RAW, CP and GS are shown in
Fig. 8 together with the Gadobutrol ADC value estimated from DTI. We computed the percentage difference for each computed
ADC and compared with ADC estimated from DTI. For the CP method, the average difference was 37±8% in grey matter,
-5±11% in white matter and for the GS method, the average difference was 250±22% in grey matter, 68±18% in white matter.
3 Discussion
The glymphatic system proposes that the paravascular network facilitates brain-wide transportation by bulk flow. Several
mathematical modeling studies have been performed at the micro-level, but to our knowledge, our current study is the first study
to investigate this process based on human imaging data at the macro-level. Our investigations are based on the distribution of
Gadobutrol in CSF and brain tissue up to 48 hours after intrathecal injection. Our results here are supportive of the glymphatic
system in the sense that the ADC estimated from the Gadobutrol distribution is higher than corresponding numbers obtained
from DTI. Hence, our study suggests that at longer time scales, the slow glymphatic system has an impact.
We assumed that the white matter was isotropic, however, it is well-known that the white matter is anisotropic. The
main reason for our choice was that introducing anisotropy would result in a model with many more free variables, requiring
substantial parameter tuning, and consequently result in less predictability. Furthermore, it can be seen in Fig. 5 that the
reconstruction is quite good. Demanding that the transport in the CSF was governed by a diffusion process yielded a much
larger error in the synthetic test case and this assumption should probably be avoided.
In our approach we have employed the FreeSurfer toolkit to segment and register grey and white matter surfaces. FreeSurfer
provides segmentations with sub-voxel accuracy, which means that at the boundaries towards the ventricles and subarachnoid
space, the surface boundary is usually in the interior of a voxel rather than at the voxel boundaries. The consequence is that the
raw data appear to have noisy image intensities at the boundaries which cut voxels. For this reason, we investigated two different
approaches to interpret the data at the boundaries, in addition to using the raw data itself. We observed in Fig. 8 that the GS
method increased the computed ADC with approximate 250±22% in grey matter, while the CP method corresponded best with
-5±11% difference to the ADC estimated with DTI in white matter. However, it should be noted that the CP method imposes
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Figure 7. The images shows the ventricular wall after 12 hours. The upper row shows the observations with following
preprocessing left to right: Raw observations, projection of CSF value onto the boundary, Gaussian smoothing. The middle row
shows the corresponding states with the regularization parameters α,β ,γ = (10−6,1.0,1.0). The bottom row shows the
corresponding states with the regularization parameters α,β ,γ = (10−6,100.0,100) .
Figure 8. The images shows the average ADC estimated with DTI and the computed ADC in grey and white matter for
different sampling methods and regularization parameters α ∈ (10−6,10−4),β ∈ (1.0,10.0),γ ∈ (0.0,0.01,1.0) and number of
time steps k ∈ (24,48). The error bars show the standard deviation.
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concentration values in the CSF onto the tissue boundaries, not accounting for the transverse propagation of MRI contrast
agent through a membrane, like the pia mater or the endothelial layer of the ventricles. Hence, potentially, an unnaturally large
concentration gradient at the boundary that is caused by a partial barrier rather than the white matter itself may have resulted
in the low ADC seen when using this method. Which of the methods that best depicted the actual boundary concentration
is unknown and would need to be determined by phantom studies. Another limitation is that we have not yet been able to
assess the diffusivity of Gadobutrol and have have relied on literature values for the free diffusion coefficient of a similar mass
molecule as a substitute for Gadobutrol. However, it should be noted that even though the concentration values appear noisy at
the boundaries, Fig.6, the interior reconstructions appear accurate, Fig. 5.
Concerning the imaging, a current limitation is that standard T1 weighted MRI images have higher resolution and SNR
than corresponding T1-maps. In detail, the intrathecal contrast enhanced T1 weighted volume scans had 1.0 mm slice thickness,
while the T1-map slice thickness was 4.0 mm. This means that the calculation of the concentration at boundaries can suffer from
mismatch of tissue and CSF. Furthermore, the T1-map sequence is designed to estimate the T1 times in tissue, and therefore
does not give accurate values for the CSF. The average T1 relaxation time for the CSF in left lateral ventricle was 181±349ms,
compared to the value 1000-5500 ms that can be found in the literature20 and we used the literature values to compute the
concentration in the CSF. We also estimated the T1 relaxation time for grey and white matter to be 1200±271 and 819±180
ms, which compares better with the literature values ranging 1470-1800 ms in grey and 1084-1110 ms in white matter21.
The ADC of water in this study was measured with DTI to be 1.0± 0.4× 10−3mm2/s in grey matter and 0.9± 0.3×
10−3mm2/s in white matter. It has been reported that ADC of extracellular water in young and healthy subjects was
0.78−1.09×10−3 in the cortical grey matter and 0.7−0.9×10−3mm2/s in white matter22. Although our values match with
the DTI values of this study, the white matter seem to be on the upper threshold. This can be explained by the fact that subjects
with dementia typically have higher ADC values, less anisotropy and greater variation in the white matter23. Thus, the DTI
values found in this study seems to correspond with the literature values. Based on the raw data, our estimated Gadobutrol
ADC was 23±10% and 82±4% larger in the grey and white matter, respectively, than what the DTI data corresponds to for
Gadobutrol.
Previous mathematical modeling studies at the micro-level2, 3 suggest that diffusion dominates in the interstitium. However,
diffusion depends on molecular size as described by the Stokes-Einstein equations and large molecules are transported slower
than small molecules24. Convective flow of solutes, on the other hand, is independent of the molecular size. Furthermore,
transport has been reported to be independent of molecular size25, a fact that suggests convective transport. In fact, convective
velocities of 0.8− 4× 10−3mm/s has been demonstrated or estimated8, 26–28, indicating that the solute transport would be
dominated by convection for large molecules, whereas similar to diffusion for smaller molecules, such as water. Gadobutrol
is in this context a molecule of moderate size, i.e., 604 Da, and hence not ideally suited for the study of bulk flow for larger
molecules such as Aβ (4.5 kDa) or CSF-τ (45 kDa). In fact, Gadobutrol is predicted to have a Pechlet number less than one2, 28
which from these micro-level studies would imply that the distribution of Gadobutrol is governed mainly by diffusion.
Studies4–6 have found that dispersion in the paravascular spaces adds less than a factor two to diffusion for solute
transportation. However, all these studies were done with modeling that was on the micro-scale over shorter time periods. To
the authors’ knowledge, the only other study29 that has considered macroscopic modeling on the time-scales of hours and days,
where uncertainties representing both variations in ADC and paravascular velocities where modelled with extensive testing
using Monte Carlo methods. They found that, in particular, the CSF tracer distribution within the deep white matter found
in11 could not be explained by diffusion alone. Recent high-resolution MRI imaging of paravascular spaces in a rat’s brain
points towards significant contributions from white matter paravascular spaces connected to the ventricles30. It should also be
mentioned that the permeability of the white matter is several orders of magnitude higher than the grey matter31, 32 and may as
such be more susceptible to bulk flow than grey matter.
In conclusion, we computed that the ADC in grey and white matter and found that in both cases the ADC was somewhat
larger than estimates based on DTI alone. Thus, indicating that there is potential for enhanced solute transportation in the brain
over a longer time period. There are, however, a number of uncertainties that needs to be taken into account, for instance the
resolution of DTI and T1 mapping.
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4 Supplementary
4.1 Constructing the synthetic solutions to assess accuracy and robustness.
Below we will discuss the parameter identification and its sensitivity with respect to the regularization parameters, noise,
number of observations and time-resolution of the forward model. The manufactured observations used in (2) were obtained by
forward computation of (3) with the Dirichlet boundary condition defined as
g(t) = 0.3+0.167t−0.007t2 for 0≤ t ≤ 24. (5)
The initial condition was set to 0 everywhere, the time step was dt = 0.24, and the diffusion coefficients were selected to be
DΩ1 = 1000.0, DΩ2 = 4.0, DΩ3 = 8.0 (6)
4.2 Additional results: Assessment of accuracy and robustness on a synthetic test case
We will in this section present additional results that was not presented in the main text, Sec. 2.2. The convergence was
monitored for a wide range of parameters, some shown in Figure 13, and we saw the similar convergence for ADC and boundary
conditions for α ∈ (10−6,10−4) and β ∈ (10−4,1). Furthermore, the method was found robust with respect to the noise as
illustrated in the Figure 9.
The variation in the number of observations was tested with 5,10 and 20 evenly spaced observations over the course of 24
hours. This was done together with 10 times steps, 20 time steps and 40 time steps. Illustrative results are shown in Figure 12,
which shows that a high number of time steps compared to observations causes oscillations (e.g. purpule line) at the boundary
for α  β . This is counteracted by selecting high values of the temporal regularization β relatively to α hereby enforcing
smoothness (e.g. blue line). For example, in the geometry with grey and white matter, it was observed that the ADC error
increased by a factor ≈ 4 for α ∼ β relative to the case where β  α for the case with 20 time steps and 10 observations.
4.3 MRI contrast agent concentration - image signal relation
Below, we briefly describe the relationship between the imaging signal seen in Figure 2 and the underlying MRI contrast agent
concentration. We remark that we use notations that are common in medical literature, which includes the use of two letter
symbols. Hence, we will also use two letter symbols, such as TE and TR, to keep the notation consistent with the presentation
in33, 34. The MRI contrast agent concentration c causes the longitudinal(spin-lattice) relaxation time T1 to shorten with the
following relation
1
T c1
=
1
T 01
+ r1c. (7)
The superscripts indicate relaxation time with MRI contrast agent T c1 and without MRI contrast agent T
0
1 , while r1 is the
relaxivity constant for the MRI contrast agent in a medium. The MRI observations were obtained using a MRI sequence
known as Magnetization Prepared Rapid Acquisition Gradient Echo (MPRAGE) with an inversion prepared magnetization.
The relation between the signal and the relaxation time is non-linear, and is expressed with the following equations. The MRI
signal value S for this sequence can be expressed as
S=Mn sinθe−TE/T
∗
2 , (8)
with TE and θ respectively denoting the echo time and the flip angle, and Mn is the magnetization for the n-echo that we
described below. Also T ∗2 is the transverse magnetization caused by a combination of spin-spin relaxation and magnetic field
inhomogeneity, defined as
1
T ∗2
=
1
T2
+ γ∆Bin. (9)
Here T2 is the transverse (spin-spin) relaxation time, γ is the gyromagnetic ratio and ∆Bin is the magnetic field inhomogeneity
across a voxel. The expression (8) can be simplified by neglecting the exponential term, since TE << T ∗2 is a general trait for
this MRI sequence. Thus, (8) becomes
S=Mn sinθ . (10)
Magnetization for the n-echo Mn is defined as33:
Mn =M0
[
(1−β ) (1− (αβ )
n−1
1−αβ +(αβ )
n−1(1− γ)+ γ(αβ )n−1 Me
M0
]
(11)
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with
Me
M0
=−
1−δ +αδ (1−β ) 1−αβm1−αβ +αδ (αβ )m−1−αmρ
1+ραm
 . (12)
Using the following definitions
α = cos(θ)
β = e−
Tb/Tc1
δ = e−
Ta/Tc1
γ = e−
Tw/Tc1
ρ = e−
TR/Tc1
Tw = TR−Ta−Tb(m−1).
(13)
Here Tb is known as the echo spacing time, Ta is the inversion time, Tw the time delay, TR as the repetition time, m is the
number of echoes and M0 is a calibration constant for the magnetization. The center echo denoted as n=m/2 will be the signal
that we will consider when estimating concentration of the MRI contrast agent. Given (10), the relative signal increase can be
written as
Sc
S0
=
Mcn sin(θ)
M0n sin(θ)
. (14)
We define that
f (T1) =Mn/M0. (15)
Figure 11 shows f (T1) in CSF, grey and white matter. This gives the following relation
f (T c1 )
f (T 01 )
=
Sc
S0
(16)
The signal difference between observation times were adjusted in11. Thus we can express the change in T1 due to MRI contrast
agent as
f (T c1 ) =
Sc
S0
f (T 01 ) (17)
and then estimate the concentration using (7). The T 01 values were obtained by T1 mapping of the brain using a MRI sequence
known as MOLLI5(3)313. This takes into account patient specific characteristic, such as tissue damage. Tissue damage can be
observed in the MRI due to a lower signal in the white matter compared to healthy white matter tissue, thus damaged tissue have
different T1 relaxation time. The MRI contrast agent concentration was estimated in a preprocessing step, using the parameters
obtained from the T1-map, MPRAGE MRI protocol11 and the value for r1 found in35. The values of the function (15) was
computed for T1 ∈ (200,4000) creating a lookup table. The lookup table was utilized with the baseline signal increase to
estimate T c1 , and then the concentration was computed using (7).
4.4 Diffusion tensor imaging
DTI images provide apparent diffusion coefficients (ADC) for water molecules (18Da) on short time-scales. A processed DTI
image is shown in Figure 11 with the largest ADC (shown in red in the middle figure) to be around 1.3e−3mm2/s.
In order to compare the computed diffusion coefficient, we need to estimate the ADC for Gadovist (604 Da)36 by utilizing (1)
together with the tortuosity and the free diffusion coefficient for Gadovist. The tortuosity in the white and grey matter was
estimated using (1) with the ADC obtained from DTI and the self-diffusion of water which is 3.0×10−3mm2/s at 37oC37. We
used the free diffusion coefficient for Gd-DPTA (550 Da)38, which was reported in39 to be 3.8×10−4mm2/s, as a surrogate for
Gadovist. This is based on the Stokes-Einstein equation, which states that molecules with similar weight will have similar
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diffusion coefficients24. Furthermore, we need to assume that the tortuosity is independent for molecules with mass lower than
1kDa, i.e. not large proteins. The fractional anisotropy is defined as
FA2 =
3
2
(λ1−MD)2+(λ2−MD)2+(λ3−MD)2
λ 21 +λ
2
2 +λ
2
3
, (18)
with the mean diffusivity MD, closely related to ADC, defined as
MD=
λ1+λ2+λ3
3
. (19)
In these equations λi denotes the eigenvalues of the diffusion tensor. FA is a common measure of anisotropy and shown in the
right-most image in Figure 11 for our patient.
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Figure 9. The upper row shows the manufactured observation, A) Shows the manufactured observation at time-point 24 with
no noise added. B) Shows the manufactured observation after 12 hours with noise range of (-0.15,0.15). C) Shows the
manufactures observation after 12 hours with noise range of (-0.3,0.3). The lower row shows the results with optimized
parameter obtained with α = 0.0001, β = 1.0 and k = 20. D) Shows the resulting state given the observation in A. E) Shows
the resulting state given the observation in B .F) Shows the resulting state given the observation in C.
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Figure 10. The image shows the function defined in (15) where the white region indicates T1 values for white matter, the grey
region indicates T1 values for grey matter, the blue region indicates T1 values for CSF.
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Figure 11. The left panel shows the anatomical map. The middle panel shows the apparent diffusion coefficients (ADC)
obtained from DTI. The right panel shows the computed fractional anisotropy (FA) from the DTI at a color coded scale.
Figure 12. The image displays plots over time for a selection of points at the boundary of Ω1 with different regularization
parameters and number of time steps k. The left panel shows the legend for the plot over time, together with the selection of
points. The middle panel shows the average boundary value g for different regularization parameter with k = 10. The right
panel shows the average boundary value g for different regularization parameter with k = 40.
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Figure 13. Convergence plots of the diffusion coefficients, boundary conditions and functional (2) with respect to different α
and β values.
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